Value Hunters: Look To Recursion Pharmaceuticals Inc (RXRX)
Currently, there are 388.78M common shares owned by the public and among those 322.67M shares have been available to trade. The company’s stock has a 5-day price change of -10.04% and 10.06% over the past three months. RXRX shares are trading -24.54% year to date (YTD), with the 12-month market performance down to -21.93% lower. […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Hogging The Spotlight Today
Currently, there are 388.78M common shares owned by the public and among those 302.39M shares have been available to trade. The company’s stock has a 5-day price change of 13.30% and 30.88% over the past three months. RXRX shares are trading -18.76% year to date (YTD), with the 12-month market performance up to 7.95% higher. […]
Analyst Expect Big Moves From Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
Currently, there are 388.78M common shares owned by the public and among those 302.41M shares have been available to trade. The company’s stock has a 5-day price change of 22.96% and -2.88% over the past three months. RXRX shares are trading -28.30% year to date (YTD), with the 12-month market performance up to 0.28% higher. […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) – Suitable For Long Term Buy?
Currently, there are 226.26M common shares owned by the public and among those 221.60M shares have been available to trade. The company’s stock has a 5-day price change of -7.69% and -27.76% over the past three months. RXRX shares are trading -42.19% year to date (YTD), with the 12-month market performance down to -15.93% lower. […]
Reassessing The Changing Outlook For Recursion Pharmaceuticals Inc (RXRX)
Currently, there are 226.26M common shares owned by the public and among those 221.54M shares have been available to trade. The company’s stock has a 5-day price change of -22.19% and -14.80% over the past three months. RXRX shares are trading -38.13% year to date (YTD), with the 12-month market performance down to -8.55% lower. […]
These Numbers Could Change Investor Views For Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
Currently, there are 226.26M common shares owned by the public and among those 223.17M shares have been available to trade. The company’s stock has a 5-day price change of 18.07% and 19.88% over the past three months. RXRX shares are trading -20.49% year to date (YTD), with the 12-month market performance up to 49.90% higher. […]
Stick With Recursion Pharmaceuticals Inc (RXRX). The Bull Are Alive And Well
Currently, there are 291.36M common shares owned by the public and among those 226.84M shares have been available to trade. The company’s stock has a 5-day price change of 1.19% and 7.06% over the past three months. RXRX shares are trading -30.83% year to date (YTD), with the 12-month market performance up to 15.40% higher. […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX): To Buy Or Not To Buy, That Is The Question
Recursion Pharmaceuticals Inc (RXRX) concluded trading on Wednesday at a closing price of $6.68, with 4.46 million shares of worth about $29.82 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -19.90% during that period and on October 30, 2024 the price saw a […]
Investors Should Take Note Of Recursion Pharmaceuticals Inc (RXRX)
Recursion Pharmaceuticals Inc (RXRX) concluded trading on Wednesday at a closing price of $6.33, with 3.96 million shares of worth about $25.05 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -20.28% during that period and on October 23, 2024 the price saw a […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX): Do Not Miss The Gain Train
Recursion Pharmaceuticals Inc (RXRX) concluded trading on Wednesday at a closing price of $7.01, with 4.51 million shares of worth about $31.65 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -6.16% during that period and on October 16, 2024 the price saw a […]
